Jiayi Huang1, Xue Bai1, Xiaofeng Xie1, Liping Chen1, Xiaofeng Lan1, Qiuyi Zhang1, Lin Song1, Pengjiao Hong2,3, Caiwen Du1,*
Oncologie, Vol.24, No.1, pp. 131-145, 2022, DOI:10.32604/oncologie.2022.019881
Abstract Background: Vinorelbine can be used to treat metastatic breast cancer as a single agent or in combination with
other chemotherapy agents, although there is little real-world data for its use, particularly the oral form, in China.
The current study aimed to explore the efficacy and safety of oral vinorelbine in patients with metastatic breast
cancer in real-world clinical practice. Methods: A total of 194 patients with metastatic breast cancer received oral
vinorelbine as a treatment between February 2017 and January 2021 at the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences… More >
Login
Register
